RETRACTED: Oxaliplatin activates P53/miR‐34a/survivin axis in inhibiting the progression of gastric cancer cells

Abstract Introduction The purpose of this research was to determine how the P53/microRNA‐34a (miR‐34a)/survivin pathway contributes to oxaliplatin‐induced (L‐OHP) cell inhibition in gastric cancer. Methods The BGC‐823 gastric cancer cells were selected, and we examined their viability following trea...

Full description

Bibliographic Details
Published in:Immunity, Inflammation and Disease
Main Authors: Qiang Guo, Xin‐Yuan Wang, Yan‐Chang Zhai, Yong‐Wei Dong, Qing‐Si He
Format: Article
Language:English
Published: Wiley 2024-09-01
Subjects:
Online Access:https://doi.org/10.1002/iid3.70004